MAIA Biotechnology Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SOLAS CAPITAL MANAGEMENT, LLC | 08/14/2026 | 3.03 M | $4.36 M | -29.47% | 4.99% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2026 | 2.50 M | $3.60 M | 0.00% | 4.11% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.41 M | $3.48 M | 16.36% | 3.97% |
| 683 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 1.07 M | $1.54 M | 0.00% | 1.75% |
| CENTRIC WEALTH MANAGEMENT | 08/06/2026 | 796.72 K | $1.11 M | 0.00% | 1.31% |
| CABLE CAR CAPITAL LLC | 08/14/2026 | 514.58 K | $741.00 K | -20.65% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 504.38 K | $726.57 K | 39.92% | 0.83% |
| BLEICHROEDER LP | 08/13/2026 | 500.00 K | $720.00 K | 0.00% | 0.82% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 415.70 K | $598.61 K | 100.00% | 0.68% |
| BLACKROCK, INC. | 08/07/2026 | 403.01 K | $580.34 K | 214.91% | 0.66% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 336.69 K | $484.83 K | 68.92% | 0.55% |
| STATE STREET CORP | 08/07/2026 | 201.75 K | $290.52 K | 45.20% | 0.33% |
| BLEAKLEY FINANCIAL GROUP, LLC | 08/05/2026 | 181.62 K | $261.54 K | 100.00% | 0.30% |
| NORTHERN TRUST CORP | 08/13/2026 | 125.17 K | $180.25 K | 138.24% | 0.21% |
| MORGAN STANLEY | 08/13/2026 | 104.02 K | $149.78 K | 650.54% | 0.17% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 76.00 K | $109.44 K | 111.11% | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 50.38 K | $72.55 K | 100.00% | 0.08% |
| ENVESTNET ASSET MANAGEMENT INC | 08/03/2026 | 44.35 K | $63.86 K | 100.00% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 35.22 K | $50.72 K | 100.00% | 0.06% |
| PVG ASSET MANAGEMENT CORP | 07/01/2026 | 34.14 K | $49.15 K | 0.00% | 0.06% |
| UBS GROUP AG | 08/13/2026 | 33.44 K | $48.15 K | -35.60% | 0.06% |
| CITADEL ADVISORS LLC | 09/02/2026 | 24.89 K | $35.84 K | 100.00% | 0.04% |
| CETERA INVESTMENT ADVISERS | 08/12/2026 | 22.75 K | $32.76 K | 100.00% | 0.04% |
| LAZARI CAPITAL MANAGEMENT, INC. | 07/23/2026 | 21.75 K | $31.32 K | 100.00% | 0.04% |
| ATRIA INVESTMENTS, INC | 07/28/2026 | 21.10 K | $30.38 K | 100.00% | 0.03% |
| CENTERPOINT ADVISORY GROUP | 07/29/2026 | 15.73 K | $22.65 K | 0.00% | 0.03% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 07/15/2026 | 14.80 K | $21.31 K | 0.00% | 0.02% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 11.40 K | $16.42 K | 0.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 8.33 K | $12.00 K | 0.00% | 0.01% |
| DAYTONA STREET CAPITAL LLC | 08/03/2026 | 7.50 K | $10.80 K | 0.00% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 4.15 K | $5.98 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 3.21 K | $4.62 K | 100.00% | 0.01% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 455 | $655 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 228 | $321 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 210 | $302 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 200 | $288 | 100.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 150 | $216 | 581.82% | 0.00% |
| FMR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 07/30/2026 | 0 | $0 | -100.00% | 0.00% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE PLANNING | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| RITHOLTZ WEALTH MANAGEMENT | 08/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CATALYST FUNDS MANAGEMENT PTY LTD | 08/10/2026 | 0 | $0 | -100.00% | 0.00% |
| CURIO WEALTH, LLC | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
MAIA Biotechnology Inc institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of MAIA Biotechnology Inc. The most heavily invested institutionals were:
Solas Capital Management, LLC: 3.03 M
Alyeska Investment Group, L.P.: 2.5 M
VANGUARD CAPITAL MANAGEMENT LLC: 2.41 M
683 Capital Management, LLC: 1.07 M
Centric Wealth Management: 796,723
Cable Car Capital LLC: 514,583
22.25% of MAIA Biotechnology Inc stock is owned by institutional investors.
Institutional investors have bought a total of 14.76 M shares in the last 24 months. This purchase volume represents approximately $21.99 M in transactions.